A
Adicet Bio D
D
ACET
0.69270
USD
-0.03
(-4.39%)
مغلق
حجم التداول
17,299
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
57,292,957
الأخبار المقالات
العنوان: Adicet Bio
القطاع: Healthcare
الصناعة: Biotechnology
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.